NCT06037733View on ClinicalTrials.gov

Primary Tumor Radiotherapy Omitting CTV for Patients With Advanced NSCLC Responded to Immunotherapy and Chemotherapy

NARecruitingINTERVENTIONAL

Enrollment

134

Participants

Timeline

Start Date

March 13, 2024

Primary Completion Date

March 13, 2026

Study Completion Date

October 8, 2027

Conditions

Advanced Non-Small Cell Squamous Lung CancerRadiotherapyImmunotherapy

Interventions

RADIATION

CTV omitted or delineated

Patients who responded to the therapy (immunotherapy and chemotherapy) were randomly (1:1) assigned into CTV-omitted radiotherapy group or CTV-delineated radiotherapy group.

Trial Locations (1)

430079

RECRUITING

Hubei Cancer Hospital, Wuhan

All Listed Sponsors

lead

Hubei Cancer Hospital

OTHER